Medicine and Dentistry
Antidiabetic Activity
5%
Beta Cell
43%
Bone
15%
Bone Strength
8%
Caloric Intake
6%
Collagen
5%
Development
5%
Diabetes
54%
Diabetes Mellitus
12%
Diabetic Obesity
11%
Exenatide
15%
Fat
25%
Food Intake
5%
Gastric Inhibitory Polypeptide
75%
Gastrointestinal Hormone
11%
Glucagon
16%
Glucagon Like Peptide 1
31%
Glucagon Like Peptide 1 Receptor
13%
Glucagon Like Peptide 2
5%
Gut
6%
Hydrocortisone
6%
Incretin
14%
Insulin Resistance
13%
Lipid Diet
10%
Liraglutide
5%
Maturity Onset Diabetes of the Young
13%
Ob/Ob Mouse
9%
Oxyntomodulin
6%
Pancreatic Islet
23%
Physical Activity Level
6%
Programmed Cell Death
6%
Receptor
33%
Streptozocin
19%
Therapeutic Procedure
50%
Vasopressin V1a Receptor
5%
Vasopressin V1b Receptor
5%
Water-Electrolyte Imbalance
6%
Pharmacology, Toxicology and Pharmaceutical Science
Antidiabetic Agent
31%
Apoptosis
7%
Biological Activity
10%
Dipeptidyl Peptidase IV
8%
Enzyme
6%
Exendin 4
23%
Glucagon Like Peptide 1 Receptor Agonist
7%
Glucagon-Like Peptide 1 Receptor
15%
Glucagon-Like Peptide-1
51%
Insulin
77%
Metformin
7%
Mouse
57%
Non Insulin Dependent Diabetes Mellitus
19%
Ob/Ob Mouse
22%
Oxyntomodulin
10%
Peptide
40%
Receptor Agonist
7%
Receptor Antagonist
12%
Rodent
5%
Streptozotocin
16%
Tarantula
5%
Biochemistry, Genetics and Molecular Biology
Apoptosis
5%
Body Weight
9%
Bone
8%
C-Terminus
5%
Cell Function
13%
Cell Survival
9%
Cholecystokinin
8%
Dipeptidyl Peptidase
6%
Fat
38%
Gastrin
7%
Glucagon-Like Peptide 1 Receptor
9%
Glucagon-Like Peptide-1
19%
Glucose
100%
Glucose Blood Level
10%
Glucose Homeostasis
20%
Hybrid
13%
Insulin Release
27%
N-Terminus
7%
Ob/Ob Mouse
14%
Receptor Antagonist
21%
Streptozotocin
10%
Transdifferentiation
6%